X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC PHARMA with Divis Laboratories - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs DIVIS LABORATORIES - Comparison Results

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA DIVIS LABORATORIES ALEMBIC PHARMA/
DIVIS LABORATORIES
 
P/E (TTM) x 26.7 18.3 145.8% View Chart
P/BV x 6.1 4.0 153.7% View Chart
Dividend Yield % 0.8 1.6 49.5%  

Financials

 ALEMBIC PHARMA   DIVIS LABORATORIES
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-16
DIVIS LABORATORIES
Mar-16
ALEMBIC PHARMA/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs7922,484 31.9%   
Low Rs443918 48.3%   
Sales per share (Unadj.) Rs167.0142.3 117.4%  
Earnings per share (Unadj.) Rs38.241.9 91.1%  
Cash flow per share (Unadj.) Rs42.046.3 90.6%  
Dividends per share (Unadj.) Rs4.0010.00 40.0%  
Dividend yield (eoy) %0.60.6 110.2%  
Book value per share (Unadj.) Rs84.9161.5 52.6%  
Shares outstanding (eoy) m188.52265.47 71.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.712.0 30.9%   
Avg P/E ratio x16.240.6 39.8%  
P/CF ratio (eoy) x14.736.7 40.0%  
Price / Book Value ratio x7.310.5 69.1%  
Dividend payout %10.523.9 43.9%   
Avg Mkt Cap Rs m116,383451,525 25.8%   
No. of employees `000NA3.7 0.0%   
Total wages/salary Rs m4,2143,649 115.5%   
Avg. sales/employee Rs ThNM10,184.4-  
Avg. wages/employee Rs ThNM984.1-  
Avg. net profit/employee Rs ThNM2,998.5-  
INCOME DATA
Net Sales Rs m31,48737,764 83.4%  
Other income Rs m55848 6.5%   
Total revenues Rs m31,54238,612 81.7%   
Gross profit Rs m10,06014,138 71.2%  
Depreciation Rs m7221,182 61.1%   
Interest Rs m3723 158.6%   
Profit before tax Rs m9,35613,781 67.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,1602,662 81.1%   
Profit after tax Rs m7,19411,119 64.7%  
Gross profit margin %31.937.4 85.3%  
Effective tax rate %23.119.3 119.5%   
Net profit margin %22.829.4 77.6%  
BALANCE SHEET DATA
Current assets Rs m15,06630,947 48.7%   
Current liabilities Rs m7,6745,195 147.7%   
Net working cap to sales %23.568.2 34.4%  
Current ratio x2.06.0 33.0%  
Inventory Days Days67117 57.4%  
Debtors Days Days4185 47.7%  
Net fixed assets Rs m8,23717,027 48.4%   
Share capital Rs m377531 71.0%   
"Free" reserves Rs m15,41642,341 36.4%   
Net worth Rs m16,00542,877 37.3%   
Long term debt Rs m05 0.0%   
Total assets Rs m24,59449,684 49.5%  
Interest coverage x255.2595.0 42.9%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.30.8 168.4%   
Return on assets %29.422.4 131.1%  
Return on equity %44.925.9 173.3%  
Return on capital %58.732.2 182.3%  
Exports to sales %55.785.3 65.4%   
Imports to sales %10.422.9 45.5%   
Exports (fob) Rs m17,55132,198 54.5%   
Imports (cif) Rs m3,2838,654 37.9%   
Fx inflow Rs m17,81132,270 55.2%   
Fx outflow Rs m5,3188,775 60.6%   
Net fx Rs m12,49323,496 53.2%   
CASH FLOW
From Operations Rs m9,30410,379 89.6%  
From Investments Rs m-3,105-4,135 75.1%  
From Financial Activity Rs m-1,959-6,241 31.4%  
Net Cashflow Rs m4,2403 128,484.8%  

Share Holding

Indian Promoters % 74.1 52.0 142.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 11.8 24.6%  
FIIs % 9.1 19.0 47.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 17.2 80.8%  
Shareholders   49,328 31,796 155.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   SUN PHARMA  MERCK LTD  NOVARTIS  FULFORD INDIA  DR. REDDYS LAB  

Compare ALEMBIC PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens in Red; Infosys Tanks as CEO Vishal Sikka Resigns(09:30 am)

Asian indices are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.2%, while the Hang Seng is down 0.7%. The Nikkei 225 is trading lower by 0.9%.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Aug 18, 2017 10:40 AM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS